C12N 2500/99
Serum-free medium
C12N2500/99 (Serum-free medium) appears on 196 US grants and 343 published applications in this corpus.
Search patents in C12N- Granted patents
- 196
- Published applications
- 343
- Assignees
- 215
- Inventors
- 643
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 5 |
| 2004 | 0 | 2 |
| 2005 | 0 | 3 |
| 2006 | 0 | 2 |
| 2007 | 3 | 3 |
| 2008 | 2 | 6 |
| 2009 | 3 | 7 |
| 2010 | 2 | 14 |
| 2011 | 3 | 13 |
| 2012 | 13 | 19 |
| 2013 | 3 | 10 |
| 2014 | 15 | 10 |
| 2015 | 28 | 11 |
| 2016 | 7 | 8 |
| 2017 | 4 | 12 |
| 2018 | 13 | 21 |
| 2019 | 5 | 25 |
| 2020 | 13 | 24 |
| 2021 | 12 | 31 |
| 2022 | 11 | 28 |
| 2023 | 16 | 32 |
| 2024 | 14 | 19 |
| 2025 | 16 | 15 |
| 2026 | 13 | 22 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Ex vivo proliferation of epithelial cells29 Sep 2026US 12,747,425 B2Propagenix Inc.
- MDCK suspension cell lines in serum-free, chemically-defined media for vaccine production30 Jun 2026US 12,667,612 B2Fujifilm Biosciences Inc.
- Compositions and methods of preparing airway cells16 Jun 2026US 12,655,393 B2Yale University
- Productivity-enhanced antibody and method for producing same31 Mar 2026US 12,590,164 B2Yonsei University BioHealth Technology Holdings, Inc.
- Mesenchymal stromal cells as a reprogramming source for iPSC induction31 Mar 2026US 12,590,295 B2The University of Hong Kong
- SIRPalpha Knockout iPSC-derived and CAR-comprising Macrophages with Enhanced Anti-tumor Activity24 Sep 2026US 2026/0284104 A1Wisconsin Alumni Research Foundation
- Composition containing extracellular matrix and matrix-bound vesicles for producing extracellular matrix and preparation method therefor24 Sep 2026US 2026/0286308 A1Hlb Cell Co., Ltd
- Media and methods for differentiating t cells from hematopoietic stem cells17 Sep 2026US 2026/0272984 A1The Regents of the University of California
- Compositions and methods of preparing airway cells10 Sep 2026US 2026/0265697 A1Yale University
- Methods for the production of hepatic stellate cells from human pluripotent stem cells6 Aug 2026US 2026/0226420 A1FUJIFILM Holdings America Corporation
Most cited
By later US patents
- Medium for growing human embryonic stem cells127US 7,297,539 B2Geron Corporation · 2007
- Culture system for rapid expansion of human embryonic stem cells97US 7,410,798 B2Geron Corporation · 2008
- Cardiac muscle regeneration using mesenchymal stem cells78US 7,514,074 B2Osiris Therapeutics, Inc. · 2009
- Cardiac muscle regeneration using mesenchymal stem cells30US 7,892,829 B2Osiris Therapeutics, Inc. · 2011
- Cardiac muscle regeneration using mesenchymal stem cells27US 8,158,121 B2Osiris Therapeutics, Inc. · 2012